AKTIVITAS NANOEMULSI MINYAK AGARWOOD BOUYA (Aquilaria agallocha) TERHADAP BAKTERI MULTIRESISTEN ANTIBIOTIK DAN NON-RESISTEN

Yulianto Ade Prasetya
| Abstract views: 241

Abstract

Multiresistant bacteria are responsible for increasing morbidity, mortality, and health care costs. Multiresistant bacteria such as Methicillin Resistant Staphylococcus aureus (MRSA), Escherichia coli producing Extended Spectrum Beta Lactamases (ESBLs), and Klebsiella pneuomoniae producing ESBLS are resistant to more than three classes of antibiotics so that alternative natural-based treatments are needed to prevent the spread of resistance. This research aims to determine the activity of Agarwood bouya (Aquilaria agallocha) oil nanoemulsion against multiresistance and non-resistance antibiotic. Nanoemulsion is made by magnetic stirrer and sonicator. The variations of Agarwood Bouya oil used are 1%, 5%, 10%, 15%, and 20%. The size of the nanoemulsion formed was analyzed using a Particle Size Analyzer (PSA), while its clarity was measured by a UV-VIS spectrophotometer. Agarwood oil nanoemulsion activity test was carried out by disk diffusion method. The results showed that agarwood oil nanoemulsion with a concentration of 1% had the smallest size is 17.7 nm with a percent transmittance of 99.35%. The agarwood bouya oil nanoemulsion 20% was only able to inhibit ESBLs-producing E. coli by 3.3 mm and was included in the weak category. The non-resistant E. coli bacteria were able to actively inhibit with the inhibition zone at 13.3mm.

Keywords

Multiresistant bacteria are responsible for increasing morbidity, mortality, and health care costs. Multiresistant bacteria such as Methicillin Resistant Staphylococcus aureus (MRSA), Escherichia coli producing Extended Spectrum Beta Lactamases (ESBLs), a

References

Agustinisari, I., E.Y. Purwani, N. Harimurti, dan S. Yuliani. 2014. Aktivitas Antimikroba Nanoemulsi MInyak Biji Pala. Jurnal Penelitian Pascapanen Pertanian. 11(1): 1-8.

Bilia, A.R., Guccione, C., Isacchi, B., Righeschi, C., Firenzuoli, F., and Bergonzi, M.C. 2014. Essential Oils Loaded in nanosystems: a developing strategy for a succesful therapeutic approach. Evidence-based Complementary and Alternative Medicine. 2014: 1-14.

Brooks, G.F., Carroll, K.C., Butel, J.S., Morse, S.A. 2017. Jawetz, Melnick & Adelberg’s Mikrobiologi Kedokteran Edisi 27. Penerbit Buku Kedokteran. Jakarta.

Canton, R and Coque, T. M. 2008. Prevalence and spread of Extended Spectrum Beta Lactamases producing Enterobacteria in Europe. Clinical Microbiology and Infection.14(1): 144-153

Chander, A. and Shrestha, C.D. 2013. Prevalence of Extended Spectrum Beta Lactamase Producing Escherichia coli and Klebsiella pneumoniae urinary isolates in a tertiary care hospital in Kathamndu, Nepal. BMC Research Notes. 6 (487): 1-6.

Dye, C. After 2015: Infectious disease in a new era of health and development. Philosophical Transactions of The Royal Society B. 369: 20130426.

Iravani S, H. Korbekandi, S.V. Mirmohammadi, B. Zolfaghari B. 2019. Synthesis of silver nanoparticles: Chemical, physical, and biological methods. Research in Pharmaceutical Sciences. 9 (6): 385 – 406.

Irawan, A. 2019. Kalibrasi Spektrofotometri Sebagai Penjaminan Mutu Hasil Pengukuran dalam Kegiatan Penelitian dan Pengujian. Indonesian Journal of Laboratory. 1(2): 1-9.

Kock, R., Becker, K., Cookson, B., Van Gemert-Pijnen, J.E., Harbath, S. 2010. Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Eurosurvelillance. 15(41): 19688-91.


Refbacks

  • There are currently no refbacks.